Zenotech Laboratories Limited

BOM:532039 ISIN:INE486F01012

Zenotech Laboratories Limited (Zenotech) is an India-based company that is principally engaged in the manufacture and trading of pharmaceuticals. The Company has launched 15 generic chemical oncology and anesthesiology products in India. Zenotech has three biological products: recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), recombinant human granulocyte colony stimulating factor (G-CSF) and interlukin-2 (IL-2). All the three are used in the cancer therapy area. The Company’s wholly owned subsidiaries include Zenotech Farmaceutica Do Brasil Limitada, Zenotech Laboratories Nigeria Limited and Zenotech Inc. On May 31, 2007, the Company incorporated a wholly owned subsidiary Hemarus Biologicals Limited. 
 
     

查看其它语言版本

新闻

1月22日澳洲股市:卖空禁令助市

🕔1/22/2009 1:00:28 PM 20603

因为市场对全球银行业的担忧被再度引发,昨天澳洲股市在金融股的拖累下收低。基本指数S&P/ASX200下跌1%,或33.8点,报3442.8点,综合指数下跌0.9%,或30.2点,报3394.8点。监管机构澳大利亚证券投资委员会决定延长禁止进行有担保的金融债券卖空交易的期限,或将给银行业带来积极推动。

阅读全文
###

39,326 公司背景浏览

  • 本页浏览人次: (过去7日: 15) (过去30日: 58) (自发布以来: 7062) 

公司详细信息